A one-time treatment tweaked their genes — and lowered their cholesterol
Heart HealthA one-time treatment tweaked their genes — and lowered their cholesterolDoctors have never had so many cholesterol-lowering drugs at their disposal, but getting patients to take them every day is difficult. Gene-editing could open a new frontier.Listen to this article with a free account00:0000:00Leila Register / NBC News; Getty ImagesShareAdd NBC News to GoogleApril 6, 2026, 7:03 AM EDTBy David CoxChristos Soteriou was 29 when he needed a quadruple bypass surgery. Four arteries in his heart had become so clogged with plaque that blood could no longer flow through them. Subscribe to read this story ad-free Get unlimited access to ad-free articles and exclusive content.It’s a surprisingly young age to need such a surgery, but extremely high levels of cholesterol run in Soteriou’s family — a genetic condition called familial hypercholesterolemia. His father died of heart disease at 46; his son was diagnosed with elevated cholesterol at 14; and Soteriou himself, now 51, has had two heart attacks since his operation. Christos Soteriou, left, with his son Jade. Soteriou has familial hypercholesterolemia, a genetic condition that causes extremely high cholesterol levels. Courtesy Jade SoteriouHe’s tried statins and a newer drug, Repatha, to lower his cholesterol, but nothing worked.So, when the opportunity came to join an early-stage clinical trial investigating a cutting-edge way to lower dangerously high cholesterol with a one-time treatment, he jumped at the chance. “I wasn’t too worried, because I’ll try anything at this point,” said Soteriou, from South Australia.The experimental treatment would use CRISPR, a gene-editing tool likened to biological scissors, to make precise cuts in the DNA to turn off a liver gene that prevents lipids — fatty substances including LDL cholesterol and triglycerides — from being cleared from the blood. By turning off the gene, called ANGPTL3, blood lipid levels should fall.Gene editing has emerged as a game-changing therapy...المصدر: NBC News | Source: NBC News
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة NBC News. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by NBC News. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.


